INSR and obesity disorder: Animal studies highlight Neu-1’s role in obesity, insulin resistance (IRES), and non-alcoholic fatty liver disease (NAFLD) by regulating adipocyte hypertrophy, insulin receptor (IR) signaling, and hepatic lipid metabolism [26,30,31,32].